Metformin Therapy and Breast Cancer Incidence in the Ha’il Region
Background: Metformin is a drug used to treat patients with type 2 diabetes, especially those who suffer from obesity. It is also used in the treatment of women with polycystic ovary syndrome (PCOS). This disease is related to insulin resistance and multiplied blood sugar ranges. Furthermore, it has...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-01-01
|
| Series: | Healthcare |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9032/11/3/321 |
| _version_ | 1797624517263097856 |
|---|---|
| author | Mhdia Osman Taif Muqbel Ahad Abduallh Shuruq Alanazi Nasrin E. Khalifa Weam M. A. Khojali Halima Mustafa Elagib Weiam Hussein Marwa H. Abdallah |
| author_facet | Mhdia Osman Taif Muqbel Ahad Abduallh Shuruq Alanazi Nasrin E. Khalifa Weam M. A. Khojali Halima Mustafa Elagib Weiam Hussein Marwa H. Abdallah |
| author_sort | Mhdia Osman |
| collection | DOAJ |
| description | Background: Metformin is a drug used to treat patients with type 2 diabetes, especially those who suffer from obesity. It is also used in the treatment of women with polycystic ovary syndrome (PCOS). This disease is related to insulin resistance and multiplied blood sugar ranges. Furthermore, it has been established that the use of metformin improves the menstrual cycles and ovulation rates of these women. Methods: A structured questionnaire was conducted to determine the prevalence of breast cancer among women using metformin in the Ha’il region. Result: The incidence of breast cancer among women using metformin in the Ha’il region is very low. Thus, it can be said that breast cancer cases declined among diabetics taking metformin. This means that metformin use is associated with a lower risk of breast cancer in women with type 2 diabetes, even in cases where these women have a family history of breast cancer. Conclusions: According to previous findings, metformin has been linked to lower breast cancer risk in women with type 2 diabetes. Furthermore, the findings of this study corroborate the literature on this subject by indicating that there is a substantial connection between metformin use and a lower risk of breast cancer in women with type 2 diabetes. However, further in vitro and in vivo experiments are crucial to investigate the protective effect of metformin against breast cancer and to confirm our findings. |
| first_indexed | 2024-03-11T09:43:29Z |
| format | Article |
| id | doaj.art-11ec1798ea6347f096e09926412c2886 |
| institution | Directory Open Access Journal |
| issn | 2227-9032 |
| language | English |
| last_indexed | 2024-03-11T09:43:29Z |
| publishDate | 2023-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Healthcare |
| spelling | doaj.art-11ec1798ea6347f096e09926412c28862023-11-16T16:43:39ZengMDPI AGHealthcare2227-90322023-01-0111332110.3390/healthcare11030321Metformin Therapy and Breast Cancer Incidence in the Ha’il RegionMhdia Osman0Taif Muqbel1Ahad Abduallh2Shuruq Alanazi3Nasrin E. Khalifa4Weam M. A. Khojali5Halima Mustafa Elagib6Weiam Hussein7Marwa H. Abdallah8Department of Clinical Pharmacy, Faculty of Pharmacy, University of Ha’il, P.O. Box 2440, Ha’il 55476, Saudi ArabiaStudent College of Pharmacy, University of Ha’il, Ha’il 55476, Saudi ArabiaStudent College of Pharmacy, University of Ha’il, Ha’il 55476, Saudi ArabiaStudent College of Pharmacy, University of Ha’il, Ha’il 55476, Saudi ArabiaDepartment of Pharmaceutics, Faculty of Pharmacy, University of Ha’il, Ha’il 55476, Saudi ArabiaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ha’il, Ha’il 55476, Saudi ArabiaDepartment of Pharmacology, Faculty of Medicine, University of Ha’il, Ha’il 55476, Saudi ArabiaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ha’il, Ha’il 55476, Saudi ArabiaDepartment of Pharmaceutics, Faculty of Pharmacy, University of Ha’il, Ha’il 55476, Saudi ArabiaBackground: Metformin is a drug used to treat patients with type 2 diabetes, especially those who suffer from obesity. It is also used in the treatment of women with polycystic ovary syndrome (PCOS). This disease is related to insulin resistance and multiplied blood sugar ranges. Furthermore, it has been established that the use of metformin improves the menstrual cycles and ovulation rates of these women. Methods: A structured questionnaire was conducted to determine the prevalence of breast cancer among women using metformin in the Ha’il region. Result: The incidence of breast cancer among women using metformin in the Ha’il region is very low. Thus, it can be said that breast cancer cases declined among diabetics taking metformin. This means that metformin use is associated with a lower risk of breast cancer in women with type 2 diabetes, even in cases where these women have a family history of breast cancer. Conclusions: According to previous findings, metformin has been linked to lower breast cancer risk in women with type 2 diabetes. Furthermore, the findings of this study corroborate the literature on this subject by indicating that there is a substantial connection between metformin use and a lower risk of breast cancer in women with type 2 diabetes. However, further in vitro and in vivo experiments are crucial to investigate the protective effect of metformin against breast cancer and to confirm our findings.https://www.mdpi.com/2227-9032/11/3/321breast cancerdiabetesmetformin |
| spellingShingle | Mhdia Osman Taif Muqbel Ahad Abduallh Shuruq Alanazi Nasrin E. Khalifa Weam M. A. Khojali Halima Mustafa Elagib Weiam Hussein Marwa H. Abdallah Metformin Therapy and Breast Cancer Incidence in the Ha’il Region Healthcare breast cancer diabetes metformin |
| title | Metformin Therapy and Breast Cancer Incidence in the Ha’il Region |
| title_full | Metformin Therapy and Breast Cancer Incidence in the Ha’il Region |
| title_fullStr | Metformin Therapy and Breast Cancer Incidence in the Ha’il Region |
| title_full_unstemmed | Metformin Therapy and Breast Cancer Incidence in the Ha’il Region |
| title_short | Metformin Therapy and Breast Cancer Incidence in the Ha’il Region |
| title_sort | metformin therapy and breast cancer incidence in the ha il region |
| topic | breast cancer diabetes metformin |
| url | https://www.mdpi.com/2227-9032/11/3/321 |
| work_keys_str_mv | AT mhdiaosman metformintherapyandbreastcancerincidenceinthehailregion AT taifmuqbel metformintherapyandbreastcancerincidenceinthehailregion AT ahadabduallh metformintherapyandbreastcancerincidenceinthehailregion AT shuruqalanazi metformintherapyandbreastcancerincidenceinthehailregion AT nasrinekhalifa metformintherapyandbreastcancerincidenceinthehailregion AT weammakhojali metformintherapyandbreastcancerincidenceinthehailregion AT halimamustafaelagib metformintherapyandbreastcancerincidenceinthehailregion AT weiamhussein metformintherapyandbreastcancerincidenceinthehailregion AT marwahabdallah metformintherapyandbreastcancerincidenceinthehailregion |